M&A Deal Summary |
|
|---|---|
| Date | 2015-07-02 |
| Target | Biocom ZAO |
| Sector | Life Science |
| Buyer(s) | Lupin |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1968 |
| Sector | Life Science |
| Employees | 24,006 |
| Revenue | 221.9B INR (2025) |
Lupin is an innovation-led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, APIs and biotechnology products. Lupin was founded in 1968 and is based in Mumbai, Maharashtra.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 11 |
| Sector: Life Science M&A | 4 of 9 |
| Type: Add-on Acquisition M&A Deals | 3 of 7 |
| Country: Russia M&A | 1 of 1 |
| Year: 2015 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-09-30 |
Laboratorios Grin S.A. de C.V.
Mexico City, Mexico Laboratorios Grin S.A. de C.V. is a specialty pharmaceutical company engaged in the development, manufacturing & commercialization of branded Ophthalmic products. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-07-24 |
Temmler Pharma & Co. KG
Marburg, Germany Temmler Pharma GmbH & Co. KG is a provider of Central Nervous System (CNS) products and specialty products that address rare disease areas like Myasthenia Gravis, Huntington disease as well as fast-growing dermatology products for anti-wart treatment. |
Buy | - |
